Navigation Links
Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet
Date:12/1/2007

hol such as disulfiram.

It is important that Kaletra oral solution is taken with food. Kaletra tablets may be taken with or without food. It is important that Kaletra tablets are swallowed whole and not be chewed, broken or crushed.

Cases of pancreatitis have been reported in patients taking Kaletra. Liver problems, which can be fatal, have also been reported. Patients should tell their doctor if they have had liver disease such as chronic hepatitis B or C as they are at increased risk for severe and potentially fatal liver adverse events. These patients may require blood tests for control of liver function.

Redistribution, accumulation or loss of body fat may occur in patients receiving combination antiretroviral therapy. Patients should contact their doctor if they notice changes in body fat.

In patients taking protease inhibitors, increased bleeding (in patients with hemophilia type A and B) has been reported.

Combination antiretroviral therapy may cause new cases of diabetes and high blood sugar or worsening of existing diabetes, as well as increased fats and raised lactic acid in the blood. The long-term risks for complications due to increases in triglycerides and cholesterol are not known at this time. In addition, large amounts of triglycerides have been considered a risk factor for pancreatitis.

In some patients with advanced HIV infection and a history of opportunistic infection, signs and symptoms of inflammation from previous infections may occur soon after anti-HIV treatment is started. Symptoms of infection should be reported to a doctor immediately.

Some patients taking combination antiretroviral therapy may develop a bone disease called osteonecrosis. Signs and symptoms are joint stiffness, aches and pains (especially in the hip, knee and shoulder) and difficulty in movement. These symptoms require that patients contact their doctor.

In lopinavir/ritonavir adult clinical trials, the very commonl
'/>"/>

SOURCE Abbott Laboratories
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. World AIDS Day Teleconference for Media, Including Helen Epstein, Author of the Invisible Cure, and Beatrice Were, Ugandan Womens Rights Advocate
2. Children of depressed moms do better when dad is involved, SLU researcher finds
3. High pollution linked to poor lung function growth in children in Mexico City
4. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement
5. Obese Children Miss More School Days
6. Ultra-Runner to Run 63 Marathons in 63 Days for Children with Incurable Disease
7. Psoriasis Cure Now offers Back to School Resources for Parents of Children with Psoriasis
8. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
9. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
10. Practice-based intervention has sustained benefits for children and families
11. 1.5 million children could be saved
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...n (a) levels boost cardiovascular disease risk fo...y News) -- If you,re worried about reducing your r...at you should quit smoking, eat a healthful diet, ...eck, and make sure your cholesterol levels aren,t ...ein (a) levels are? , Well, if you don,t have ...
(Date:10/10/2008)...mpany committed to helping people address health n.../ -- In these troubling,economic times, people may... may feel that they don,t have the money to visit ...a survey by the National Association of,Insurance ... -- Twenty-two percent of Americans say that they ...
(Date:10/10/2008)...Oct. 10 /PRNewswire/ -- Do you think that the blin...d town? Attend the October,17 open house at the Vi...ion Impaired, and see how instructors there empowe...ve, fulfilling lives through non-visual,techniques...1 Azalea Avenue, is holding an open house to,celeb...
(Date:10/10/2008)...omy serving as tipping point for behavior change, ...-- More than half of,Americans (51 percent) believ...are system, but major changes are needed, accordin...urvey was released today by the,Employee Benefit R...tes,Inc., and was underwritten by the Principal Fi...
Breaking Medicine News(10 mins):Health News:Little-Known Fat Can Be a Heartbreaker 2Health News:Little-Known Fat Can Be a Heartbreaker 3Health News:Healthcare Resources Available in Difficult Times 2Health News:Healthcare Resources Available in Difficult Times 3Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3
...search has proved that a new drug named histatin, ...ills the fungus- Candida albicans,// which is resp...s known that candidiasis, also known as thrush, is...ts and ulcers on the membranes of the mouth, tongu...
...udies on vitamin E seemed to suggest that suppleme...cancer and heart problems. //Recently, a study pub... says the reality of taking vitamin E supplements ...searchers had studied patients with cardiovascular...
...ur kind of immunity may lead you to blindness. Acc...ience journal, //scientists had been able to find ...ight. In search of what is commonly known as blin... up with a gene that may cause macular degeneratio...
... has been shown that the drug Rimonabant (Acompli... can help obese patients keep weight off // . Supp... resulted in a significant decrease in body weight...cularly dangerous visceral fat. It also improved H...
Other Medicine News:
(Date:10/7/2008)...wire/ -- Prometheus Laboratories Inc., a,specialty...from its,development of PROMETHEUS(R) IBS Diagnost...wel syndrome (IBS). The findings suggest measurabl...arkers in blood samples,between IBS and non-IBS pa...mbined with a proprietary algorithm, led to the de...
(Date:10/7/2008)...Newswire/ -- The Texas Cardiac Arrhythmia,Institut...lected as one of,only a few sites in the nation to... a new device to treat persistent atrial fibrillat...d research center specializing in heart,rhythm dis...al Center and,Texas Cardiovascular Consultants., ...
(Date:10/7/2008)...tate Prevented Immunologic Changes Induced by ..., Additional Data Indicates Potential in Treating ... /- Alba Therapeutics Corporation,pre... at the American,College of Gastroenterology (ACG)...LIN 1001-004, the first Phase IIa trial conducted ...
(Date:10/7/2008)... 7 /- A study published in the,scient...self-renewal,reported that InVitria,s ( http://ww...m albumin) was an effective replacement to bovine ...titled, "The ground state of embryonic stem cell,s...astim as a recombinant,albumin in place of animal-...
Breaking Medicine Technology:Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Male Partner Violence Hurts Womens Health Worldwide 15952 1Male Partner Violence Hurts Womens Health Worldwide 15952 2Study Finds Mass Media Campaigns Alone Can Effectively Reduce High Risk Sexual Behavior Among Impulsive Sensation Seeking Young Adults 15950 1Study Finds Mass Media Campaigns Alone Can Effectively Reduce High Risk Sexual Behavior Among Impulsive Sensation Seeking Young Adults 15950 2Study Finds Mass Media Campaigns Alone Can Effectively Reduce High Risk Sexual Behavior Among Impulsive Sensation Seeking Young Adults 15950 3PAHEF Discusses Neglected Diseases and Disaster Preparedness with Innovative Leaders 15948 1PAHEF Discusses Neglected Diseases and Disaster Preparedness with Innovative Leaders 15948 2IPC The Hospitalist Company Added to Russell 2000 Index 15946 1IPC The Hospitalist Company Added to Russell 2000 Index 15946 2
...o., March 06, 2007 /PRNewswire-FirstCall/ --,Repli...ts Phase II,clinical trial using faropenem medoxom...itis media (AOM), a common infection of the,middle...hat it met,its primary objective to show that faro...the middle ear and to permit the dose,selection fo...
...., March 06, 2007 /PRNewswire-FirstCall/ --,Advanc...completed,Phase III multi- center clinical studies... therapeutic will be presented during,the National...ings,taking place April 10th through 14th in Orlan...cheduled to be presented on,Wednesday, April 11, 2...
Other Medicine Technology:Replidyne Phase II Pediatric Trial Meets Primary Objective 2Replidyne Phase II Pediatric Trial Meets Primary Objective 3Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 2Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 3Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 4
Portable shields for your safety and convenience.
Full-Height Radiation Barriers provide full-body shielding and reduce eye strain during extended procedures.
0.5 mm Pb protection with height-adjustment for patient and practitioner. Measures 18"L x 24"W adjusts 36" to 56" in height at lowest height (36") bottom hem remains 12" from floor. 5 leg base for ma
Ball-and-socket center mount can rotate 360, allowing them to be turned hoirzontally, vertically, or at any angle. Very versatile! Available with or without torso placement contour cutout and in thre
Medicine Products: